CA2329941A1 - Methodes de traitement des bouffees de chaleur et de la gynecomastie - Google Patents

Methodes de traitement des bouffees de chaleur et de la gynecomastie Download PDF

Info

Publication number
CA2329941A1
CA2329941A1 CA002329941A CA2329941A CA2329941A1 CA 2329941 A1 CA2329941 A1 CA 2329941A1 CA 002329941 A CA002329941 A CA 002329941A CA 2329941 A CA2329941 A CA 2329941A CA 2329941 A1 CA2329941 A1 CA 2329941A1
Authority
CA
Canada
Prior art keywords
subject
lhrh antagonist
hot flashes
lhrh
gynaecomastia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002329941A
Other languages
English (en)
Inventor
Marc B. Garnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Praecis Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2329941A1 publication Critical patent/CA2329941A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des méthodes destinées à empêcher les bouffées de chaleur ou la gynécomastie chez un sujet. Selon ces méthodes, on administre un antagoniste de la lulibérine a un sujet qui nécessite un traitement inhibant les bouffées de chaleur ou la gynécomastie. Selon une réalisation préférée, l'invention concerne une méthode qui inhibe les bouffées de chaleur en rapport avec la ménopause et qui consiste à administrer un antagoniste de la luciférien à un sujet qui nécessite un traitement contre les bouffées de chaleur en rapport avec la ménopause.
CA002329941A 1998-04-27 1999-04-27 Methodes de traitement des bouffees de chaleur et de la gynecomastie Abandoned CA2329941A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6714098A 1998-04-27 1998-04-27
US09/067,140 1998-04-27
PCT/US1999/009081 WO1999055358A1 (fr) 1998-04-27 1999-04-27 Methodes de traitement des bouffees de chaleur et de la gynecomastie

Publications (1)

Publication Number Publication Date
CA2329941A1 true CA2329941A1 (fr) 1999-11-04

Family

ID=22073965

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002329941A Abandoned CA2329941A1 (fr) 1998-04-27 1999-04-27 Methodes de traitement des bouffees de chaleur et de la gynecomastie

Country Status (8)

Country Link
EP (1) EP1073454A4 (fr)
JP (1) JP2002512976A (fr)
KR (1) KR20010043014A (fr)
CN (1) CN1307481A (fr)
AU (1) AU770565B2 (fr)
CA (1) CA2329941A1 (fr)
NZ (1) NZ507504A (fr)
WO (1) WO1999055358A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE60113142T2 (de) 2000-10-30 2006-07-06 University Of Zurich Verwendung von gnrh-analogue zur behandlung der harninkontinenz
EP1495768A4 (fr) * 2002-04-12 2007-12-05 Takeda Pharmaceutical Agents pour prevenir/traiter les bouffees de chaleur
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
WO2007021970A2 (fr) * 2005-08-15 2007-02-22 Praecis Pharmaceuticals, Inc. Formes pharmaceutiques stables et methodes d'utilisation de celles-ci
EP2692352A4 (fr) 2011-03-31 2014-12-24 Shiseido Co Ltd Suppresseur de bouffées de chaleur
US10062357B2 (en) 2012-05-18 2018-08-28 Reald Spark, Llc Controlling light sources of a directional backlight
US9235057B2 (en) 2012-05-18 2016-01-12 Reald Inc. Polarization recovery in a directional display device
US9678267B2 (en) 2012-05-18 2017-06-13 Reald Spark, Llc Wide angle imaging directional backlights
US9188731B2 (en) 2012-05-18 2015-11-17 Reald Inc. Directional backlight
US9709723B2 (en) 2012-05-18 2017-07-18 Reald Spark, Llc Directional backlight
JP2016529764A (ja) 2013-06-17 2016-09-23 リアルディー インコーポレイテッド 指向性バックライトの光源の制御
KR102366346B1 (ko) 2013-10-14 2022-02-23 리얼디 스파크, 엘엘씨 지향성 백라이트를 위한 광 입력
CN106068533B (zh) 2013-10-14 2019-01-11 瑞尔D斯帕克有限责任公司 定向显示器的控制
JP6962521B2 (ja) 2014-06-26 2021-11-05 リアルディー スパーク エルエルシー 指向性プライバシーディスプレイ
US9835792B2 (en) 2014-10-08 2017-12-05 Reald Spark, Llc Directional backlight
WO2016105541A1 (fr) 2014-12-24 2016-06-30 Reald Inc. Réglage de la rotondité perçue dans une image stéréoscopique d'une tête
EP3283906B1 (fr) 2015-04-13 2020-09-23 RealD Spark, LLC Dispositifs de rétroéclairage directionnel d'imagerie à grand angle
WO2017074951A1 (fr) 2015-10-26 2017-05-04 Reald Inc. Système de confidentialité intelligent, appareil et procédé associés
US10459321B2 (en) 2015-11-10 2019-10-29 Reald Inc. Distortion matching polarization conversion systems and methods thereof
EP3374822B1 (fr) 2015-11-13 2023-12-27 RealD Spark, LLC Éléments de surface pour rétroéclairages directionnels d'imagerie
CN114143495A (zh) 2016-01-05 2022-03-04 瑞尔D斯帕克有限责任公司 多视角图像的注视校正
WO2022060673A1 (fr) 2020-09-16 2022-03-24 Reald Spark, Llc Dispositif d'éclairage externe de véhicule
WO2024030274A1 (fr) 2022-08-02 2024-02-08 Reald Spark, Llc Affichage proche de l'œil de suivi de pupille

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3724520C2 (de) * 1986-07-31 1996-01-11 Madaus Ag Neue 3-Aryl-3-Cycloalkyl-piperidin-2,6-dion-Derivate
EP0301850A3 (fr) * 1987-07-31 1990-10-31 Syntex (U.S.A.) Inc. Analogues de la lhrh et steroide 19-nor-progestatifs à usage thérapeutique
US4992421A (en) * 1988-04-19 1991-02-12 Abbott Laboratories Luteinizing hormone releasing hormone antagonist
DE593491T1 (de) * 1991-04-25 1994-11-17 Romano S.-Cergue Deghenghi LHRH-Antagonisten.
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides

Also Published As

Publication number Publication date
JP2002512976A (ja) 2002-05-08
AU770565B2 (en) 2004-02-26
AU3764299A (en) 1999-11-16
KR20010043014A (ko) 2001-05-25
EP1073454A4 (fr) 2005-03-09
NZ507504A (en) 2003-07-25
CN1307481A (zh) 2001-08-08
WO1999055358A1 (fr) 1999-11-04
EP1073454A1 (fr) 2001-02-07

Similar Documents

Publication Publication Date Title
AU770565B2 (en) Methods for treating hot flashes and gynaecomastia
US5780435A (en) Methods for treating prostate cancer with LHRH-R antagonists
KR920007831B1 (ko) 지효성(持효性)미크로 캡슐의 제조방법
WO1997022357A9 (fr) Procedes de traitement du cancer de la prostate avec des antagonistes de la luliberine
CZ206699A3 (cs) Farmaceutické přípravky s vodonerozpusným komplexem pro trvalé uvolňování léčiv
HU193910B (en) Process for production of microcapsules giving activity in case of their soluability in water
Okada et al. One-month release injectable microspheres of leuprolide acetate inhibit steroidogenesis and genital organ growth in rats
HU225691B1 (en) Aqueous formulations of peptides
US20070066536A1 (en) Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators
EP1261363B1 (fr) PROCEDES DE TRAITEMENT DES AFFECTIONS LIEES A L'HORMONE FOLLICULOSTIMULANTE (FSH) PAR LE BIAIS D'ANTAGONISTES VIS-A-VIS DE LA GONADOLIBERINE (GnRH)
WO1998002133A1 (fr) Compositions et methodes pour le traitement de l'alopecie regionale masculine
US6703367B1 (en) Methods for treating hot flashes and gynaecomastia
PL186929B1 (pl) Zawiesiny do iniekcji długo działające i sposób ich wytwarzania
Asch et al. Prolonged suppression of plasma LH levels in male rats after a single injection of an LH‐RH agonist in poly (DL‐lactide‐co‐glycolide) microcapsules
AU775302B2 (en) Methods for treating prostate cancer with LHRH antagonists
AU2004203641B2 (en) Methods for treating LHRH-associated disorders with LHRH antagonists
AU3966799A (en) Methods for detecting lesions in dense breast tissue using lhrh antagonists
AU2008201931A1 (en) Methods for treating LHRH-associated disorders with LHRH antagonists

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead